Author name: Emily Crane

Emily Crane is a writer, producer, and editor who has covered politics, health, business, and finance for publications like The Atlantic. She's also the host of the All Work All Play Podcast. She graduated from Northwestern University's Medill School of Journalism with a focus on investigative reporting and data visualization.

Avatar of Emily Crane
february 2025 birdsellbruce final 1200x630 s

EV Shortages, Regulations, and Roadblocks: One Fleet Leader’s Battle for Compliance & Efficiency

Bruce Birdsell navigating a regulatory environment that he says doesn’t yet align with the reality of vocational fleet needs.   Fleet managers everywhere are feeling the pressure to comply with evolving emissions regulations. That includes Bruce Birdsell — a self-professed advocate for EV (electric vehicle) adoption — and fleet manager at Hermanson Company […]

EV Shortages, Regulations, and Roadblocks: One Fleet Leader’s Battle for Compliance & Efficiency Read More »

D4GVPPQ2VZBQ7OJBD6DUESIH4E

Indie Insights: Why authenticity is a competitive advantage for indie brands

The indie beauty market is experiencing explosive growth, with consumer demand for transparency and authenticity at an all-time high. According to a 2023 report by The NPD Group, indie beauty brands grew nearly 24% year-over-year, outpacing legacy brands as consumers seek out products aligned with their values. Meanwhile, as reported by Mintel, 75% of beauty

Indie Insights: Why authenticity is a competitive advantage for indie brands Read More »

6EFUJLCKIZD2RNNF2RABDCDSTI

Consumer review platform analyzes 51M reviews for key beauty industry insights

The “Shoppers Have Spoken” report, one of the largest of its kind to date, comprehensively analyzed consumer sentiment in the beauty industry and highlighted key trends that can help beauty brands refine their products, marketing, and customer engagement strategies. Danna Rabin, General Manager of UGC at Yotpo, explained the significance of using a vast dataset

Consumer review platform analyzes 51M reviews for key beauty industry insights Read More »

february 2025 tariffs 1200x630 s

Fleet Industry Braces for Impact as Tariff Battles Unfold [Updated]

Whether it’s challenges in the delivery sector or rising costs for vehicles and parts, the full impact of tariffs on the commercial fleet industry remains uncertain. February 13: Steel and Aluminum Tariffs Add to Inflation Concerns On Monday, February 10, President Donald Trump removed exceptions and exemptions from his 2018 tariffs

Fleet Industry Braces for Impact as Tariff Battles Unfold [Updated] Read More »

107330991 1699471284774 gancsos prenuvo nyc 0408

Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding

Preventative health startup Prenuvo on Thursday announced it will offer three new health assessments in addition to its flagship full-body MRI scan. The company is launching a detailed blood test, neurological scan and body composition analysis that was approved by the U.S. Food and Drug Administration in recent weeks. Prenuvo said it wants to give

Prenuvo adds new health tests to flagship full-body scan, raises $120 million in fresh funding Read More »

february 2025 geotab driver stress 1200x630 s

New Survey Reports Majority of U.S. Fleet Professionals Say Stress Impacts Driving Performance

68% of drivers report that work-related stress negatively impacts their performance, seriously affecting their wellbeing, road safety, and the economy. Photo: Pexels via Pixabay A new study released by Geotab Inc. demonstrates a need for increased support for commercial fleet drivers to address rising concerns about their wellbeing and road safety.

New Survey Reports Majority of U.S. Fleet Professionals Say Stress Impacts Driving Performance Read More »

108101530 1739386738587 gettyimages 1966457733 cfoto apharmac240131 np793

U.S. investors, Big Pharma race to find new medicines in China

A little-known biotech company stunned the biopharmaceutical industry last spring when it declared an “unprecedented” achievement: its experimental cancer drug looked more effective than Merck‘s Keytruda in a clinical trial. The company, Summit Therapeutics, licensed the drug from Chinese company Akeso Inc.  In October, a group of life science investors announced they were putting $400

U.S. investors, Big Pharma race to find new medicines in China Read More »

All Work All Play Podcast

A year in beauty: CosmeticsDesign unpacks key developments in 2024 that will impact 2025

In this episode of the Beauty 4.0 Podcast, the CosmeticsDesign editorial team looked back on the highlights of 2024. Kirsty Doolan, editor of CosmeticsDesign-Europe, said there were some surprises that she did not expect in 2024, including L’Oréal’s minority acquisition of Galderma. “Earlier in the year, I would have considered them to be rival companies.

A year in beauty: CosmeticsDesign unpacks key developments in 2024 that will impact 2025 Read More »

108100580 1739281416248 gettyimages 2194484256 PWeaver 250120 22

CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit

CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs.  The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6 per share, which was in line with Wall Street’s expectations. But CVS did not provide a revenue

CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit Read More »

Scroll to Top